Sodium Oxybate Added to Portfolio
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Sodium Oxybate Oral Solution [soe-dee-um ox-i-bate].
Sodium Oxybate Oral Solution 0.5 g/mL is available in 180 mL bottles and is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy.
Sodium Oxybate Oral Solution is a REMS product that requires distributors to be enrolled in the corresponding REMS program.
To learn more about the Sodium Oxybate REMS program, click here.





